How can someone write this and be considered a "professional"?
Vertex Pharmaceuticals Earnings: Here’s Why Shares are Up Now
By Derek Hoffman | More Articles
April 30, 2013
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are up 0.3%.
Results: Adjusted Earnings Per Share decreased 93.02% to $0.03 in the quarter versus EPS of $0.43 in the year-earlier quarter.